Skip to main content
. 2017 Jun 29;8(38):63574–63586. doi: 10.18632/oncotarget.18862

Figure 7. Forest plot and meta-analysis of the approximate 3-year progression free survival. It was similar between haplo-HCT with PT-Cy and HLA-matched HCT.

Figure 7

Haplo versus MRD (A), Haplo versus MUD (B). HCT: hematopoietic cell transplantation, PT-Cy: post-transplant cyclophosphamide, haplo: HLA-haploidentical, MRD: HLA-matched related donor, MUD: HLA-matched unrelated donor, RR: risk ratio, CI: confidence interval.